Physician profile
Judith L Schaffer
NPI 1770648453
$9,281.47
in general payments reported to CMS, 2019-2025
21 companies · $1,672 in 2025
The $1,672 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,514 · 2020: $223 · 2021: $652 · 2022: $1,394 · 2023: $1,384 · 2024: $1,442 · 2025: $1,672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,227 · Entertainment: $271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,227.08 |
| Entertainment | $271.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $2,358.53 | 2022-2025 | Infuse |
| Alcon Vision LLC | $2,164.16 | 2019-2025 | Precision7, Dailies, Precision 1 |
| Johnson & Johnson Vision Care, INC. | $1,279.06 | 2019-2025 | Acuvue |
| Coopervision INC. | $999.77 | 2019-2025 | Myday Contact Lens, Cvi Contact Lens, Misight Contact Lens |
| Optos, INC. | $652.59 | 2019-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $448.47 | 2019-2021 | |
| Glaukos Corporation | $206.60 | 2022-2025 | Photrexa Viscous and Photrexa |
| Dompe US, INC. | $166.54 | 2021-2025 | Oxervate |
| Genentech USA, INC. | $136.56 | 2019 | |
| Maculogix, INC. | $129.36 | 2020 | |
| Kala Pharmaceuticals, INC. | $125.00 | 2021 | |
| Horizon Therapeutics Plc | $103.96 | 2021 | |
| Lkc Technologies, INC. | $98.93 | 2024 | |
| Sun Pharmaceutical Industries INC. | $92.97 | 2025 | |
| Optovue, INC. | $83.22 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $74.45 | 2019 | |
| Oyster Point Pharma, INC. | $50.00 | 2023 | Tyrvaya |
| Rxsight INC | $39.63 | 2025 | Rxsight Contact Lens, Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Topcon Healthcare, INC. | $36.20 | 2024 | |
| Novo Nordisk INC | $18.23 | 2019 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Schaffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.